Formulation and evaluation of gastroretentive dosage forms of clarithromycin

AAPS PharmSciTech

Volumn 9, Issue 1, 2008, Pages 231-237

  Nama, Muralidhar ^a   Gonugunta, Chandra Sekhar Rao ^a   Reddy Veerareddy, Prabhakar ^a  

^a ST PETER'S INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Clarithromycin; Floating; H. pylori; HPMC; Peptic ulcer

Indexed keywords

BARIUM SULFATE; BICARBONATE; CLARITHROMYCIN; CRIXAN OD; HYDROXYPROPYLMETHYLCELLULOSE; POLYMER; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; HYDROXYPROPYLMETHYLCELLULOSE LACTOSE MATRIX; HYDROXYPROPYLMETHYLCELLULOSE-LACTOSE MATRIX; LACTOSE; METHYLCELLULOSE;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; CHEMICAL REACTION KINETICS; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG RETENTION; DRUG SCREENING; DRUG SOLUBILITY; DRUG TRANSPORT; GASTROINTESTINAL TRACT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN EXPERIMENT; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; MALE; MEAN RESIDENCE TIME; NORMAL HUMAN; PEPTIC ULCER; RADIODIAGNOSIS; STOMACH; TABLET FORMULATION; CHEMISTRY; DELAYED RELEASE FORMULATION; EVALUATION; INTESTINE; MATERIALS TESTING; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG COMPOUNDING; HUMANS; INTESTINES; LACTOSE; MALE; MATERIALS TESTING; METABOLIC CLEARANCE RATE; METHYLCELLULOSE; STOMACH;

EID: 44849103069     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9038-8     Document Type: Article

References (10)

1. R. Suman, R. B. Uma Maheshwari, and N. K. Jain. Clarithromycin based oral sustained release nanoparticulate drug delivery system. Indian J. Pharm. Sci. 68: 479-484 (2006).
2. F. Fraschini, F. Scaglione, and G. Dermartini. Clarithromycin clinical pharmacokinetics. Clin. Pharmacokinet. 25: 189-204 (1993).
3. P. L. Bardonnet, V. Faivre, W. J. Pugh, J. C. Piffaretti, and F. Falson. Review gastroretentive dosage forms: Overview and special case of helicobacter pylori. J. Control. Release 111: 1-18 (2006).
4. S. Arora, J. Ali, A. Ahuja, R. K. Khar, and S. Baboota. Floating drug delivery systems: Review. AAPS PharmSciTech 6 (3):E372-E390 (2005).
5. B. S. Kuchekar, A. A. Singavi, S. G. Late, and D. B. Shinde. Spectrophotometric estimation of roxithromycin and clarithromycin in pharmaceutical dosage forms. Indian Drugs 40 (1):44-45 (2003).
6. M. Rosa, H. Zia, and T. Rhodes. Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int. J. Pharm. 105: 65-70 (1994).
7. B. S. Kuchekar, A. A. Singavi, S. G. Late, and D. B. Shinde. Spectrophotometric estimation of roxithromycin and clarithromycin in pharmaceutical dosage forms. Indian Drugs 40 (1):44-45 (2003).
8. P. L. Ritger, and N. A. Peppas. A simple equation for description of solute release. J. Control. Release 5: 23-36 (1987).
9. P. Sriamornsak, N. Thirawong, and K. Korkerd. Swelling erosion and release behavior of alginate based matrix tablets. Eur. J. Pharm. Biopharm. 66 (3):435-450 (2007).
10. C. S. Brazel, and N. A. Peppas. Modeling of drug release from swellable polymers. Eur. J. Pharm. Biopharm. 49: 47-58 (2000).